ProductUpdated on 18 June 2026
Cannabis medicated chewing gums for addiction treatment
CEO at MEDICAL FLOWERS DEVELOPMENTS
MADRID, Spain
About
MFD is developing a new generation of cannabis medicated chewing gums designed to support behavioural therapies in addiction treatment.
The product is conceived as a pharmaceutical-grade, single-dose oral dosage form with controlled delivery through the buccal mucosa. The objective is to provide a complementary pharmacological tool to help manage anxiety peaks and craving during addiction treatment processes.
The first clinical program focuses on Cannabis Use Disorder (CUD), an unmet medical need with no approved pharmacological treatment today. Following this first validation, MFD aims to explore the potential of its technology in other addiction-related indications, including alcohol, cocaine and opioid dependence.
Looking for
- Distribution Partner
Applies to
- Pharmaceutical industry
- Health innovation
Organisation
Similar opportunities
Investment
Investment opportunity in cannabis medicines for addiction treatment
- Healthcare
- Seed and Development
David Molinero Caravantes
CEO at MEDICAL FLOWERS DEVELOPMENTS
MADRID, Spain
Project cooperation
Clinical and research collaborations in addiction treatment
- Planning
- Research
- Financing
David Molinero Caravantes
CEO at MEDICAL FLOWERS DEVELOPMENTS
MADRID, Spain
Partnership
Pharmaceutical partnerships for innovative addiction medicines
- Others
- Development
David Molinero Caravantes
CEO at MEDICAL FLOWERS DEVELOPMENTS
MADRID, Spain